A High-Throughput, Homogeneous, Bioluminescent Assay for Pseudomonas aeruginosa Gyrase Inhibitors and Other DNA-Damaging Agents

Kiska, 2003, Pseudomonas, 719 Hutter, 2004, Panel of Bacillus subtilis reporter strains indicative of various modes of action., Antimicrob Agents Chemother, 48, 2588, 10.1128/AAC.48.7.2588-2594.2004 Hooper, 2001, Mechanisms of action of antimicrobials: focus on fluoroquinolones., Clin Infect Dis, 32, S9, 10.1086/319370 Hoang, 2000, Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains., Plasmid, 43, 59, 10.1006/plas.1999.1441 Schweizer, 1995, An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa., Gene, 158, 15, 10.1016/0378-1119(95)00055-B Wolfgang, 2003, Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway., Dev Cell, 4, 253, 10.1016/S1534-5807(03)00019-4 Choi, 2005, An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants., BMC Microbiol, 5, 30, 10.1186/1471-2180-5-30 Herring, 2004, Conditional lethal amber mutations in essential Escherichia coli genes., J Bacteriol, 186, 2673, 10.1128/JB.186.9.2673-2681.2004 Choi, 2005, A Tn7-based broad-range bacterial cloning and expression system., Nat Methods, 2, 443, 10.1038/nmeth765 Voisey, 1998, Elimination of internal restriction enzyme sites from a bacterial luminescence ( luxCDABE) operon., Biotechniques, 24, 56, 10.2144/98241bm11 Becher, 2000, Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions., Biotechniques, 29, 948, 10.2144/00295bm04 Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high-throughput screening assays., J Biomol Screen, 4, 67, 10.1177/108705719900400206 2003 Li, 1994, Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin., Antimicrob Agents Chemother, 38, 1732, 10.1128/AAC.38.8.1732 Oliver, 2004, Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections., Antimicrob Agents Chemother, 48, 4226, 10.1128/AAC.48.11.4226-4233.2004 Brazas, 2005, Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa., Antimicrob Agents Chemother, 49, 3222, 10.1128/AAC.49.8.3222-3227.2005 Nakayama, 2000, The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage., Mol Microbiol, 38, 213, 10.1046/j.1365-2958.2000.02135.x Winsor, 2005, Pseudomonas aeruginosa genome database and PseudoCAP: facilitating community-based, continually updated, genome annotation., Nucleic Acids Res, 33, D338, 10.1093/nar/gki047 Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen., Nature, 406, 959, 10.1038/35023079 Lumish, 1975, Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid., Antimicrob Agents Chemother, 7, 159, 10.1128/AAC.7.2.159 Kohler, 1997, Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa., Antimicrob Agents Chemother, 41, 2540, 10.1128/AAC.41.11.2540 Shimizu, 1976, Pipemidic acid: its activities against various experimental infections., Antimicrob Agents Chemother, 9, 569, 10.1128/AAC.9.4.569 Sisson, 2002, Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori., Antimicrob Agents Chemother, 46, 2116, 10.1128/AAC.46.7.2116-2123.2002 De Alencar, 2005, Nitrogen mustard- and half-mustard-induced damage in Escherichia coli requires different DNA repair pathways., Mutat Res, 582, 105, 10.1016/j.mrgentox.2005.01.004 Sykora, 1992, Trichlormethine hydrochloride and correlation of its mutagenic and toxic effects on male germ cells in mice., Mutat Res, 266, 291, 10.1016/0027-5107(92)90196-9 Cepeda, 2007, Biochemical mechanisms of cisplatin cytotoxicity., Anticancer Agents Med Chem, 7, 3, 10.2174/187152007779314044 Matsui, 1993, Regulation of pyocin genes in Pseudomonas aeruginosa by positive ( prtN) and negative ( prtR) regulatory genes., J Bacteriol, 175, 1257, 10.1128/jb.175.5.1257-1263.1993 Cirz, 2006, Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin., J Bacteriol, 188, 7101, 10.1128/JB.00807-06 Lomovskaya, 2001, Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy., Antimicrob Agents Chemother, 45, 105, 10.1128/AAC.45.1.105-116.2001